Q98447870

Summary

Q98447870 is an interpellation^[1].

Key Facts

• Q98447870 authored Margareta Viklund^[2].
• Q98447870's instance of is recorded as interpellation^[3].
• Q98447870's part of the series is recorded as interpellations of the 2000/01 legislative session of the Riksdag^[4].
• Q98447870's language of work or name is recorded as Swedish^[5].
• Q98447870's publication date is recorded as +2001-03-21T00:00:00Z^[6].
• Q98447870's significant event is recorded as debate^[7].
• Q98447870's main subject is recorded as medication^[8].
• Q98447870's work available at URL is recorded as http://data.riksdagen.se/dokument/GO10353^[9].
• Q98447870's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GO10353^[10].
• Q98447870's applies to jurisdiction is recorded as Sweden^[11].
• Q98447870's legal citation of this text is recorded as ip. 2000/01:353^[12].
• Q98447870's title is recorded as läkemedelskommitté^[13].
• Q98447870's addressee is recorded as Lars Engqvist^[14].
• Q98447870's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98447870's copyright status is recorded as public domain^[16].
• Q98447870's Swedish Riksdag document ID is recorded as GO10353^[17].

Body

Works and Contributions

Q98447870 authored Margareta Viklund^[2].